This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Pulmonary Arterial Hypertension
and you are
between 18 and 80
years old
-
The phase for this study is not defined.
Show me locations

The purpose

6 months therapy of Bosentan, an endothelin antagonist, will lead to improvement in pulmonary microvascular endothelial function.

Provided treatments

  • Drug: Bosentan

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01721564. The sponsor of the trial is Prof David S Celermajer and it is looking for 8 volunteers for the current phase.
Official trial title:
Pulmonary Artery Remodelling With Bosentan